Shingo Harita
Shingo Harita publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.
- World rank
- #4,000,191 of 7,710,434 ranked researchers
- Rank in Japan
- #107,026 of 383,136
- Works
- 83
- Citations
- 1.1k
- Citations per work
- 13.4
What does Shingo Harita research?
Shingo Harita's work is mostly in Medicine (78%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6578.3%
- Medicine6578.3%
- Life Sciences1113.1%
- Everything else78.6%
- 1Pulmonary and Respiratory Medicine41% of their works
- 2Oncology32% of their works
- 3Molecular Biology10% of their works
- 4Epidemiology4% of their works
- 5Immunology3% of their works
- 6Surgery2% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Lung Cancer Diagnosis and Treatment
- Cancer therapeutics and mechanisms
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Neuroendocrine Tumor Research Advances
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Which keywords describe Shingo Harita's research?
The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Genomic Profiles, Small-Cell Lung Cancer and CT Screening.
- Cetuximab
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Fibrosis
- DNA
- CT Screening
- Genomic Profiles
- ALK Inhibitors
- Clinical Trials
- Chemotherapy
- Targeted Therapy
- EGFR Mutations
- Small-Cell Lung Cancer
- Lung Cancer
- Topoisomerases
- Idiopathic Pulmonary Fibrosis
- Neuroendocrine Tumors
- Pancreatic Neuroendocrine Tumors
- KRAS Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Chemotherapy994 topics
- Clinical Trials992 topics
- Targeted Therapy992 topics
- ALK Inhibitors521 topic
- EGFR Mutations521 topic
- Genomic Profiles471 topic
- Small-Cell Lung Cancer471 topic
- CT Screening261 topic
- Lung Cancer261 topic
- DNA201 topic
- Topoisomerases201 topic
- Fibrosis81 topic
- Idiopathic Pulmonary Fibrosis81 topic
- Immune Checkpoint Blockade71 topic
- Neuroendocrine Tumors71 topic
- PD-1 and PD-L171 topic
- Pancreatic Neuroendocrine Tumors71 topic
- Cetuximab61 topic
- KRAS Mutations61 topic
Where does Shingo Harita work?
Shingo Harita's main affiliation in the publication record is Chugoku Central Hospital, Japan.
How many publications and citations does Shingo Harita have?
OpenAlex counts 83 works and 1,110 citations for Shingo Harita, an h-index of 17, ranking #4,000,191 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shingo Harita. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.